(Q29615392)
Statements
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations (English)
McCabe MT
Ott HM
Ganji G
Korenchuk S
Thompson C
Van Aller GS
Liu Y
Graves AP
Della Pietra A 3rd
Diaz E
LaFrance LV
Mellinger M
Duquenne C
Tian X
Kruger RG
McHugh CF
Brandt M
Miller WH
Dhanak D
Verma SK
Tummino PJ
Creasy CL
6 December 2012
492
7427
108-12
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference